Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival

Journal of Clinical Oncology

Volumn 16, Issue 8, 1998, Pages 2715-2721

  Kies, Merrill S ^a   Haraf, Daniel J ^b   Athanasiadis, Ilias ^b   Kozloff, Mark ^b   Mittal, Bharat ^b   Pelzer, Harold ^b   Rademaker, Alfred W ^b   Wenig, Barry ^b   Weichselbaum, Ralph R ^b   Vokes, Everett E ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; HEAD AND NECK CANCER; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031879925     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.8.2715     Document Type: Article

References (26)

1. Tupchong L, Scott CB, Blitzer PH, et al: Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 20:21-28, 1991
2. Vokes EE, Weichselbaum RR, Lippman SM, et al: Head and neck cancer. N Engl J Med 328:184-194, 1993
3. Laramore GE, Scott CB, Al-Sarraf M, et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Reports on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23:705-713, 1992
4. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
5. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European organization for research and treatment of cancer phase III trial. J Natl Cancer Inst 88:890-899, 1996
6. Vokes EE, Ratain MJ, Mick R, et al: Cisplatin, fluorouracil and leucovorin augmented by interferon alfa2b in head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 11:360-368, 1993
7. Vokes EE, Kies MS, Haraf DJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13:876-883, 1995
8. Vokes EE, Mick R, Kies MS, et al: Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer. J Clin Oncol 14:1663-1671, 1996
9. Johnston PG, Mick R, Recant W, et al: Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. J Natl Cancer Inst 89:308-313, 1997
10. Lo TC, Wiley AL Jr, Ansfield FJ, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. AJR Am J Roentgenol 126:229-235, 1976
11. Fu KK, Phillips TL, Silverberg IJ, et al: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5:1410-1418, 1987
12. Bachaud JM, David JM, Boussin G, et al: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: Preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 20:243-246, 1991
13. Merlano M, Benasso M, Corvo R, et al: Five year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996
14. Brizel DM, Albers MA, Fisher SR, et al: A phase III trial of hyperfractionated irradiation ± concurrent chemotherapy for locally advanced carcinoma of the head and neck: superiority of combined modality treatment. Proc Am Soc Clin Oncol 16:384a, 1997 (abstr 1368)
15. Arekapudi A, Haraf D, Mittal BB, et al: Concomitant radiotherapy (XRT) and chemotherapy (FHX) with 5-fluorouracil (5-FU) and hydroxyurea (HU) for organ preservation in stage II and III squamous cell head and neck cancer (SCHNC): Preliminary results of an ongoing trial. Toronto, Canada, 4th International Conference on Head and Neck Cancer 4:118, 1996 (abstr 239)
16. American Joint Committee on Cancer: Manual for Staging of Cancer (ed 3). Philadelphia, PA, Lippincott, 1988, pp 25-62
17. Schneider M, Etienne MC, Milano G, et al: Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: A pharmacokinetic and clinical survey. J Clin Oncol 13:1656-1662, 1995
18. Goldberg RM, Hatfield AK, Kahn M, et al: Prospectively randomized north central cancer treatment group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer. J Clin Oncol 15:3320-3329, 1997
19. Taylor SG IV, Murthy AK, Caldarelli DD, et al: Combined simultaneous cisplatin/fluorouracil chemotherapy course radiation in head and neck cancer. J Clin Oncol 7:846-856, 1989
20. Athanasiadis I, Taylor S IV, Vokes EE, et al: Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. Cancer 79:588-594, 1997
21. Clark JR, Busse PM, Norris CM Jr, et al: Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for squamous cell carcinoma of the head and neck: Long-term results. J Clin Oncol 15:3100-3110, 1997
22. Hong WK, Lippman SM, Wolf GT: Recent advances in head and neck cancer - larynx preservation and cancer chemoprevention: The Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 53:5113-5120, 1993
23. Amdur RJ, Parsons JT, Mendenhall WM, et al: Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 17:279-285, 1989
24. Milano G, Etienne MC, Renee N, et al: Relationship between fluorouracil systemic exposure and tumor response and patient survival. J Clin Oncol 12:1291-1295, 1994
25. Kies MS, Haraf DJ, Stenson K, et al: Intensive combined therapy with C-DDP, 5-FU, hydroxyurea, and bid radiation (C-FHX) for stage IV squamous cancer (SCC) of the head and neck. Proc Am Soc Clin Oncol 15:314a, 1996 (abstr 886)
26. Vokes EE, Haraf DJ, Kies MS, et al: Continuous infusion (CI) paclitaxel and 5-FU with oral hydroxyurea and twice daily concomitant radiation therapy for head and neck cancer. Paris, France, 7th International Congress on Anti-Cancer Treatment 7:83, 1997 (abstr 118)